Longboard Pharmaceuticals CFO Brandi Roberts receives $1.3M in 2021
Longboard Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 13, 2022
Longboard Pharmaceuticals reported fiscal year 2021 executive compensation information on April 13, 2022.
In 2021, three executives at Longboard Pharmaceuticals received on average a compensation package of $938K, a 35% decrease compared to previous year.
Average pay of disclosed executives at Longboard Pharmaceuticals
Brandi L. Roberts, Chief Financial Officer, received $1.3M in total. 57% of Roberts' compensation, or $765K, was in option awards. Roberts also received $30K in bonus, $154K in non-equity incentive plan, $373K in salary, as well as $12K in other compensation.
Kevin R. Lind, Chief Executive Officer, received a compensation package of $875K, which decreased by 62% compared to previous year. 62% of the compensation package, or $547K, was in salary.
Philip Perera, Chief Medical Officer, earned $605K in 2021, a 1% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 13, 2022.